Ferguson Enterprises Inc. Common Stock vs Vaxcyte Inc. Common Stock — how do they compare? Ferguson Enterprises Inc. Common Stock trades at $222 (market cap $43.11B), while Vaxcyte Inc. Common Stock trades at $67.37 (market cap $10.51B). The key difference: Ferguson Enterprises Inc. Common Stock is far larger — about 4.1× Vaxcyte Inc. Common Stock's market cap, and Ferguson Enterprises Inc. Common Stock pays a 1.6% dividend while Vaxcyte Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Ferguson Enterprises Inc. Common Stock for 0 Days and Vaxcyte Inc. Common Stock for 0 Days on average.
| FERG | PCVX | |
|---|---|---|
Market Cap | $43.11B | $10.51B |
Volume | 945,793 | 2,644,694 |
Sector | Industrials | Health |
52-Week High | $267.71 | $73.82 |
52-Week Low | $214.26 | $40.32 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $49.56B | $9.14B |
Dividend Yield | 1.6% | — |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Ferguson Enterprises, Inc. distributes plumbing, HVAC, waterworks, and related building products to professional contractors, builders, and facility managers across North America, operating through branches, showrooms, and digital commerce.
Read more on FERG →Vaxcyte, Inc. is a clinical-stage vaccine company that engineers protein-based vaccines to prevent bacterial diseases such as invasive pneumococcal disease, using its proprietary cell-free protein synthesis platform to develop candidates including the pneumococcal conjugate vaccines VAX-31 and VAX-24.
Read more on PCVX →